Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04627480 · ClinicalTrials.gov registry record · Phase 4
Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial
A Phase 4 study of Insomnia and Sleep, sponsored by ProofPilot.
- Active
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04627480 is a Phase 4 study of Insomnia and Sleep that is active but no longer recruiting, run by ProofPilot. The registered enrollment target is 200 participants, above the 169-participant average among 151 other Insomnia trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04627480, a Phase 4 study of Insomnia and Sleep, is active but no longer recruiting, sponsored by ProofPilot.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device (CES) for the treatment of insomnia characterized by difficulties with sleep maintenance using a 20-minute treatment right before bedtime.
Conditions Studied
Interventions
- DEVICE Fisher Wallace Neurostimulation Device
Study Locations (1)
New York
- ProofPilot (Remote Virtual Trial) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-02-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04627480
The ClinicalTrials.gov registry entry for NCT04627480 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 169-participant average among 151 other Insomnia trials with a reported enrollment target (18% higher). The listed sponsor is ProofPilot, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Fisher Wallace Neurostimulation Device is the first listed.
NCT04627480 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04627480 about?
NCT04627480 is a clinical study titled "Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial". Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device (CES) for the treatment of insomnia characterized by difficulties with sleep maintenance using a 20-minute treatment right before bedtime.
What is the current status of trial NCT04627480?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2020-10-01. Estimated completion is 2021-02-21.
What conditions does trial NCT04627480 study?
This clinical trial studies the following conditions: Insomnia, Sleep, Insomnia Chronic.
What interventions are being tested in trial NCT04627480?
The interventions under investigation include: Fisher Wallace Neurostimulation Device (DEVICE).
Who is sponsoring clinical trial NCT04627480?
This trial is sponsored by ProofPilot, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04627480 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms
RECRUITING · Phase 4
-
Enhancing Hypnotic Medication Discontinuation in Primary Care
RECRUITING · Phase 4
-
Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes
RECRUITING · Phase 4
-
Solriamfetol and CBT-I in Patients With Insomnia Disorder
ACTIVE NOT RECRUITING · Phase 4
-
A Pilot Study of Suvorexant for Insomnia in Parkinson Disease
COMPLETED · Phase 4
-
Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.